Richard Horton on the Oxford vaccine phase 3 trial

from The Lancet in conversation with · host The Lancet

Editor-in-chief of The Lancet, Richard Horton, discusses the results of the Oxford vaccine's phase 3 trial. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Episode metadata supplied by the publisher feed · Published Dec 8, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Richard Horton on the Oxford vaccine phase 3 trial

0:00 11:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Lancet in conversation with?

This episode is 11 minutes long.

When was this The Lancet in conversation with episode published?

This episode was published on December 8, 2020.

Can I download this The Lancet in conversation with episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!